Molecular basis of PD-1 blockade by dostarlimab, the FDA-approved antibody for cancer immunotherapy - ScienceDirect
Frontiers | Variable neutralizing antibody responses to 10 SARS-CoV-2 variants in natural infection with wild- type (B.1) virus, Kappa (B.1.617.1), and Delta (B.1.617.2) variants and COVISHIELD vaccine immunization in India: utility of
Molecules | Free Full-Text | Anti-PD-L1-Based Bispecific Antibodies Targeting Co-Inhibitory and Co-Stimulatory Molecules for Cancer Immunotherapy
PDF) How to Screen for Monoclonal Gammopathy in Patients With a Suspected Amyloidosis
Frontiers | Mechanisms of action of monoclonal antibodies in oncology integrated in IMGT/mAb-DB
Frontiers | Mechanisms of action of monoclonal antibodies in oncology integrated in IMGT/mAb-DB
Viruses | Free Full-Text | Development of Therapeutic Monoclonal Antibodies for Emerging Arbovirus Infections
Low quantity and quality of anti-spike humoral response is linked to CD4 T-cell apoptosis in COVID-19 patients | Cell Death & Disease
FOXP3 Monoclonal Antibody (FJK-16s), APC (17-5773-82)
Kappa (a) and lambda (b) mRNA by in situ hybridization (showing... | Download Scientific Diagram
Frontiers | Biotherapeutic Antibodies for the Treatment of Head and Neck Cancer: Current Approaches and Future Considerations of Photothermal Therapies
Viruses | Free Full-Text | Development of Therapeutic Monoclonal Antibodies for Emerging Arbovirus Infections
Frontiers | Variable neutralizing antibody responses to 10 SARS-CoV-2 variants in natural infection with wild- type (B.1) virus, Kappa (B.1.617.1), and Delta (B.1.617.2) variants and COVISHIELD vaccine immunization in India: utility of
Frontiers | Variable neutralizing antibody responses to 10 SARS-CoV-2 variants in natural infection with wild- type (B.1) virus, Kappa (B.1.617.1), and Delta (B.1.617.2) variants and COVISHIELD vaccine immunization in India: utility of
CEP170 Monoclonal Antibody (72-413-1) (41-3200)
CD282 (TLR2) Monoclonal Antibody (TL2.1) (14-9922-82)
Development and characterization of anti-IL-5 monoclonal antibody Fab fragment for blocking IL-5/IL-5Rα binding - ScienceDirect
Low quantity and quality of anti-spike humoral response is linked to CD4 T-cell apoptosis in COVID-19 patients | Cell Death & Disease
Kappa (a) and lambda (b) mRNA by in situ hybridization (showing... | Download Scientific Diagram
Frontiers | Mechanisms of action of monoclonal antibodies in oncology integrated in IMGT/mAb-DB
Development and characterization of anti-IL-5 monoclonal antibody Fab fragment for blocking IL-5/IL-5Rα binding - ScienceDirect
![PDF] Development and validation of an antigen capture ELISA based on monoclonal antibodies specific for Listeria monocytogenes in food. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/ece3d7965e88f4d9f35c2d5fb934f6903ff62784/8-TableX-1.png "PDF] Development and validation of an antigen capture ELISA based on monoclonal antibodies specific for Listeria monocytogenes in food. | Semantic Scholar")
PDF] Development and validation of an antigen capture ELISA based on monoclonal antibodies specific for Listeria monocytogenes in food. | Semantic Scholar
Kappa Light Chain Monoclonal Antibody (TB28-2), PE (12-9970-42)
N-cadherin Monoclonal Antibody (3B9) (33-3900)
Development and characterization of anti-IL-5 monoclonal antibody Fab fragment for blocking IL-5/IL-5Rα binding - ScienceDirect
The development of immunomodulatory monoclonal antibodies as a new therapeutic modality for cancer: The Bristol-Myers Squibb experience - ScienceDirect
IgE monoclonal gammopathy: A case report and literature review - ScienceDirect
Immunohistochemical staining. H. pylori-infected gastric biopsy... | Download Scientific Diagram
